Kelley-Seegmiller syndrome due to a unique variant of hypoxanthine-guaninephosphoribosyltransferase: reduced affinity for 5-phosphoribosyl-1-pyrophosphate manifested only at low, physiological substrate concentrations
E. Zoref-shani et al., Kelley-Seegmiller syndrome due to a unique variant of hypoxanthine-guaninephosphoribosyltransferase: reduced affinity for 5-phosphoribosyl-1-pyrophosphate manifested only at low, physiological substrate concentrations, BBA-MOL BAS, 1500(2), 2000, pp. 197-203
Citations number
25
Categorie Soggetti
Medical Research General Topics
Journal title
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
A male child, who presented at the age of 3.5 years with acute renal failur
e, was diagnosed as having partial deficiency of hypoxanthine-guanine phosp
horibosyltransferase (HPRT; EC 2.4.2.8). The underlying HPRT mutation was u
nique in that the specific activity of HPRT in erythrocyte and in fibroblas
t lysates was normal, but the rate of uptake of hypoxanthine into nucleotid
es of intact cultured fibroblasts was markedly reduced (23% of normal). The
low functioning of HPRT in the intact fibroblasts was associated with decr
eased utilization of endogenously generated hypoxanthine and with decreased
utilization of the co substrate 5-phosphoribosyl-1-pyrophosphate (PRPP). T
he non-utilized hypoxanthine was excreted into the incubation medium. The a
ccumulation of PRPP was indicated by the 2.3-fold increase in the rate of u
ptake of adenine into intact cell nucleotides and by the 7.5-fold enhanceme
nt of the rate of de novo purine synthesis. Kinetic studies of HPRT activit
y in fibroblast lysates revealed reduced affinity of the enzyme for PRPP (a
pparent K-m 500 mu M in comparison to 25 mu M in control lysates), manifest
ed in low activity at low (physiological), but not at high PRPP concentrati
ons. The apparent K-m for hypoxanthine was normal (23 mu M in comparison to
14.2 mu M in control lysates). With allopurinol treatment, our patient has
had no problems since presentation, and is developing normally at 5 years
of age. (C) 2000 Elsevier Science B.V. All rights reserved.